What vitamins should be avoided when taking clarithromycin (antibiotic), especially in patients with impaired renal (kidney) or hepatic (liver) function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Clarithromycin and Vitamin Interactions

There are no clinically significant vitamin interactions that require avoidance when taking clarithromycin, with the important exception of Vitamin K in patients on anticoagulants, where monitoring is essential.

Vitamins Requiring Caution (Not Avoidance)

Vitamin K

  • Patients taking warfarin or other anticoagulants should be monitored closely when clarithromycin is added, as clarithromycin inhibits CYP3A4 metabolism and can potentiate anticoagulant effects, increasing bleeding risk 1
  • This is not a direct clarithromycin-vitamin K interaction, but rather a three-way interaction involving anticoagulant medications 1
  • Vitamin K supplementation itself does not need to be stopped, but INR monitoring should be intensified 1

Vitamin D

  • Vitamin D may theoretically interact with clarithromycin in patients taking medications metabolized by CYP3A4, but this is of minimal clinical concern in most patients 1
  • No dose adjustment or avoidance is necessary for routine vitamin D supplementation 1

Vitamin E

  • Similar to vitamin D, vitamin E has theoretical interactions with CYP3A4 substrates but does not require avoidance in patients taking clarithromycin 1

Minerals Requiring Monitoring (Not Vitamins)

Calcium, Magnesium, Iron, Zinc

  • These minerals can interact with certain antibiotics (particularly quinolones) through chelation, but clarithromycin is not affected by this mechanism 1
  • These supplements can be taken concurrently with clarithromycin without timing restrictions 1

Critical Context for Renal/Hepatic Impairment

Renal Impairment Considerations

  • In patients with CrCl <60 mL/min taking ritonavir or lopinavir-ritonavir, reduce clarithromycin dose by 50% 2, 3, 4
  • In patients with CrCl <30 mL/min taking ritonavir or lopinavir-ritonavir, reduce clarithromycin dose by 75% 2, 3, 4
  • Vitamin supplementation does not require adjustment based on renal function when taking clarithromycin 5

Hepatic Impairment Considerations

  • No clarithromycin dose adjustment is required for hepatic impairment alone 6
  • Patients with combined hepatic and renal impairment should follow renal dosing guidelines 7
  • Vitamin metabolism may be independently affected by liver disease, but this is unrelated to clarithromycin use 7

Common Pitfalls to Avoid

  • Do not confuse vitamin-drug interactions with drug-drug interactions: The primary concern with clarithromycin is its CYP3A4 inhibition affecting other medications (carbamazepine, cyclosporin, digoxin, theophylline, warfarin), not vitamins themselves 5, 8
  • Do not stop routine multivitamin supplementation when prescribing clarithromycin—there is no evidence-based reason to do so 1
  • Do not assume all antibiotics have the same vitamin interactions: Unlike quinolones which chelate with minerals, clarithromycin has no such restriction 1

Water-Soluble Vitamins

  • Vitamin C, B vitamins, and folic acid have no clinically significant interactions with clarithromycin and can be continued without concern 2
  • These vitamins are rarely deficient in uncomplicated cases and do not require special monitoring when clarithromycin is prescribed 2

References

Research

Vitamin and mineral supplements: friend or foe when combined with medications?

Journal of the American Dental Association (1939), 2014

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Clarithromycin Dosing and Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Clarithromycin Dosing Considerations in Renal Impairment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Clinical pharmacokinetics of clarithromycin.

Clinical pharmacokinetics, 1999

Guideline

Clarithromycin and Acebrophylline Drug Interaction

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.